Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novavax
Biotech
Pfizer pens $530M deal to use Novavax adjuvant on 2 programs
Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the pharma’s vaccine programs.
James Waldron
Jan 20, 2026 10:40am
FDA puts Novavax's phase 3 plan on hold for pair of vaccines
Oct 16, 2024 9:10am
Acadia brings BMS vet on board as CEO—Chutes & Ladders
Sep 27, 2024 8:30am
Novavax's 2nd round of job cuts impacted 12% of staff
Jan 31, 2024 11:57am
Novavax plans for 2nd round of cuts, including more layoffs
Nov 9, 2023 10:53am
Novavax cuts head count by 25%, hitting hundreds of jobs
May 9, 2023 6:30am
